National Institutes of Health

Grantee Website Bethesda, Maryland, United States
Purpose
to develop and distribute a high-titered anti-Vi IgG reference serum to facilitate the development of novel efficacious capsular polysaccharide Vi-typhoid conjugate vaccine candidates that may be administered during infancy. This reference serum may obviate the need for manufacturers to undergo costly clinical trials with disease outcomes to potentially having licensed commercial products faster and cheaper
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$360,593
Grant Topic
Enteric and Diarrheal Diseases
Duration (Months)
58
Grantee Location
Bethesda, Maryland, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.